date:Jun 21, 2012
FSANZ Deputy chief executive officer Melanie Fisher said that DMAA has been linked in other countries with various adverse health effects including high blood pressure and vomiting and there have been a couple of adverse health reports in Australia.
Regulatory agencies are working together to assess the products' safety and are currently seeking the assistance of retailers; importers and distributors on a withdrawal of the products, Fisher added.
The products containing DMAA or 1,3-dimethylamyla